Albion Chelated Magnesium Glycinate
Goals
$17.79 $0.59 per serving
Product analysis
Albion Chelated Magnesium Glycinate provides a favorable magnesium form to help fill low intake and support normal bone and energy functions. Benefits beyond meeting nutritional needs, including dependable everyday stress relief, remain uncertain.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality100
Magnesium bisglycinate is a favorable form for absorption. That form advantage does not establish better bone, stress or heart outcomes than other magnesium forms.
Ingredient Transparency100
The magnesium amount and exact form are clearly stated. The single-source formula is straightforward to compare with other magnesium supplements.
Value For Money70
Magnesium bisglycinate offers favorable value for the form provided. The comparison concerns magnesium quality and cost rather than a proven extra benefit from chelation.
Customer Satisfaction68
Customer feedback is generally favorable. A moderate number of ratings provides some perspective, without proving health benefits.
Product Focus67
One nutrient keeps the formula simple, though the proposed benefits span several areas. Its clearest role is covering low magnesium intake, with stress and hormone effects remaining conditional.
- Format
Powder - Container
- 5 Liquid(s)
- Per serving
- $0.59
- Customer rating
- 4.4 · 252 ratings
Goals
Impact
Highest effect
Magnesium · 400 mg
Magnesium supports normal energy metabolism and bone mineral functions, and can help fill a low dietary intake. The serving provides a substantial magnesium contribution. The bisglycinate form does not establish superior health benefits, and more magnesium does not necessarily improve outcomes when intake is already adequate.
How this product is rated for Everyday Health
Ingredient fit92
The contributing ingredients relate directly to the supplied general health functions. The contributing amounts reach the saved comparison endpoints; larger amounts do not establish greater health benefit.
Goal fit
The contributing ingredients relate directly to the supplied general health functions.
Dose adequacy
The contributing amounts reach the saved comparison endpoints; larger amounts do not establish greater health benefit.
Pathways80
The strongest recorded contribution concerns energy metabolism, with the breadth finding covering energy metabolism, bone and mineral functions.
Depth
The strongest recorded contribution concerns energy metabolism.
Breadth
The recorded contributions extend to energy metabolism, bone and mineral functions.
Evidence86
Magnesium leads the saved evidence finding. Preparation eligibility does not establish extra benefit beyond the supplied context.
Evidence strength
Magnesium provides the strongest eligible contribution; the supported health claim remains limited by its supplied nutritional or population context.
Studied preparation
The eligible contributing preparations match the saved preparation criteria; this does not establish superiority over other forms.
Formulation logic100
The contributing ingredients work independently or have their required partners present. No configured ingredient conflict was found in the supplied facts.
Partner coverage
The contributing ingredients work independently or have their required partners present.
Conflicts
No configured ingredient conflict was found in the supplied facts.
Effective doses
All ingredients retained for this finding meet its minimum amount comparison; this does not make every listed ingredient effective.
Impact
High effect
Magnesium · 400 mg
Magnesium contributes to blood-vessel function, with possible effects on arterial stiffness. Findings are inconsistent: one trial improved stiffness without lowering blood pressure, while others found no overall benefit. Support is more plausible with low magnesium status or elevated blood pressure; the supplied forms do not establish superior cardiovascular effects.
How this product is rated for Cardiovascular Support
Ingredient fit92
The relevant ingredients give this formula a clear cardiovascular connection, although it is linked to several goals.
Goal fit
The relevant ingredients give this formula a clear cardiovascular connection, although it is linked to several goals.
Dose adequacy
The amounts of the ingredients counted here reach their saved comparison anchors; this does not establish a proven effective daily dose.
Pathways54
The supplied findings concentrate on vascular tone and sodium balance. Other cardiovascular aspects have limited or no recognized coverage.
Depth
The strongest supplied connection is vascular tone and sodium balance.
Breadth
Coverage is concentrated in vascular tone and sodium balance; the other cardiovascular aspects do not reach the saved coverage threshold.
Evidence79
Magnesium provides the strongest recognized evidence here, limited to the contexts and outcomes described for that ingredient.
Evidence strength
Magnesium provides the strongest recognized evidence here, limited to the contexts and outcomes described for that ingredient.
Studied preparation
The ingredients counted at meaningful amounts are recognized as studied preparations in the saved findings.
Formulation logic100
The counted ingredients have no missing required partner or listed conflict, and reach the saved minimum amount threshold.
Partner coverage
The counted ingredients can contribute without a missing required partner.
Conflicts
No listed ingredient conflict was triggered by the supplied facts.
Effective doses
All ingredients counted in this finding reach its minimum amount threshold; that threshold is a comparison convention, not proof of effectiveness.
Impact
High effect
Magnesium · 400 mg
Magnesium may support stress-related calming when magnesium intake is low or in selected clinical settings. Broad, lasting relief from everyday stress remains uncertain. The 400 mg elemental magnesium serving meets the full quantity reference. The bisglycinate form is identified, but the supplied findings do not establish superior stress relief from this salt.
How this product is rated for Stress Relief
Ingredient fit92
Magnesium supplies the relevant nutritional contribution.
Goal fit
Magnesium is the only counted active, although the product is linked to several goals.
Dose adequacy
The 400 mg elemental magnesium serving meets the full quantity reference.
Pathways50
Magnesium's strongest assigned role is calming, with a smaller stress-hormone-related contribution.
Depth
Neural calming is the strongest covered pathway.
Breadth
Calming is the only pathway meeting the saved coverage criterion; broader stress-hormone, mood, resilience and sleep coverage is not established.
Evidence76
Magnesium supplies the evidence basis, with benefits most applicable to low-magnesium or selected clinical settings.
Evidence strength
Magnesium provides the leading evidence here, with conditional support rather than reliable general stress relief.
Studied preparation
The declared magnesium preparation meets the saved preparation criterion; this does not establish equal absorption or benefit across salts.
Formulation logic100
The counted ingredients have no missing required partner, and no configured conflict was found.
Partner coverage
The counted ingredients can contribute without an additional required partner.
Conflicts
No configured ingredient conflict was identified in the supplied facts.
Effective doses
The counted ingredient meets the saved minimum amount criterion; this does not guarantee stress relief.
Impact
High effect
Magnesium · 400 mg
Magnesium can help address fatigue and weakness caused by low magnesium intake. Its declared amount provides a substantial nutrient contribution and fully meets the saved comparison. Additional magnesium does not establish greater energy when intake is already adequate, and its biochemical role does not prove a clinical fatigue effect. None of the assessed energy pathways receives coverage in the saved findings.
How this product is rated for Energy
Ingredient fit92
Magnesium has a focused conditional nutritional role and a substantial declared amount.
Goal fit
Magnesium relates to low-intake fatigue, with broader product targeting slightly reducing focus.
Dose adequacy
The declared magnesium amount fully meets the saved comparison without defining a fatigue-treatment dose.
Pathways0
None of the assessed energy pathways receives coverage. This differs from the conditional nutritional contribution retained elsewhere.
Depth
No assessed energy pathway has a qualifying contribution.
Breadth
No assessed energy area reaches substantial coverage.
Evidence88
The supported magnesium role is filling a dietary gap associated with fatigue, without established extra energy above adequacy. The preparation meets the saved criteria.
Evidence strength
Magnesium leads the saved evidence finding, within the population and outcome limits of its supplied evidence.
Studied preparation
Credited preparations meet the saved criteria without establishing superiority of particular forms or delivery methods.
Formulation logic100
Credited ingredients clear the saved amount threshold and have no assessed missing partner or conflict.
Partner coverage
Credited ingredients work alone or have their relevant partners.
Conflicts
No assessed ingredient conflict was triggered.
Effective doses
All credited ingredients clear the saved minimum amount threshold; that threshold does not establish a clinical fatigue effect.
Impact
Highest effect
Magnesium · 400 mg
Magnesium supports electrolyte balance and blood-vessel tone, but supplementation has shown marginal and inconsistent blood-pressure effects. The 400 mg per serving reaches the saved amount plateau. The findings focus on this one aspect of heart health. The supplied information does not establish a particular magnesium form as better for blood pressure.
How this product is rated for Heart Health
Ingredient fit92
Magnesium gives the formula a focused connection to electrolyte balance and vessel tone. Magnesium reaches the saved amount plateau; larger amounts do not imply greater benefit.
Goal fit
Magnesium gives the formula a focused connection to electrolyte balance and vessel tone.
Dose adequacy
Magnesium reaches the saved amount plateau; larger amounts do not imply greater benefit.
Pathways57
The saved findings concentrate on electrolyte balance and blood-vessel tone.
Depth
Magnesium supplies the main finding for vessel tone.
Breadth
Only the electrolyte and vessel-tone aspect meets the saved coverage criterion.
Evidence89
Magnesium leads the saved evidence finding, although blood-pressure results are marginal and inconsistent. The saved preparation check is satisfied, without establishing superiority of a particular magnesium salt.
Evidence strength
Magnesium leads the saved evidence finding, although blood-pressure results are marginal and inconsistent.
Studied preparation
The saved preparation check is satisfied, without establishing superiority of a particular magnesium salt.
Formulation logic100
The counted ingredients have no missing required partner, and no specified conflict was identified. The counted amounts meet the saved minimum criterion.
Partner coverage
The counted ingredients have no missing required partner.
Conflicts
No specified ingredient conflict was identified in the supplied facts.
Effective doses
The counted nutrient contributions meet the saved minimum amount criterion.
Impact
Highest effect
Magnesium · 400 mg
Magnesium helps maintain normal bone metabolism and can fill a low dietary intake. Its role is nutritional: supplement trials do not reliably establish routine osteoporosis or fracture prevention. The declared elemental amount supports the saved contribution, without proving that a chelated form improves bone outcomes more than other forms.
How this product is rated for Bone Health
Ingredient fit92
The formula contains relevant bone nutrients, with declared amounts determining how much nutritional support is recognized.
Goal fit
The relevant ingredients connect to bone nutrition, although the product is also linked to other goals.
Dose adequacy
Declared amounts fully meet the saved nutritional benchmarks; this does not establish fracture prevention.
Pathways57
The saved findings emphasize the bone functions described below. Nutrient functions do not by themselves establish improved bone density or fewer fractures.
Depth
Mineral supply is the strongest supported aspect, led by the declared bone-related minerals.
Breadth
Coverage is concentrated on mineral supply, with more limited support across other bone-related functions.
Evidence95
Nutritional roles provide the clearest basis for support. Findings about routine bone density and fracture benefits are more limited than the saved ingredient contributions imply.
Evidence strength
Magnesium provides the strongest connection in the saved findings; the supplied evidence does not establish routine fracture prevention.
Studied preparation
The saved findings recognize the counted preparations as studied; this does not establish superior clinical outcomes for every declared form.
Formulation logic100
The recognized partners are available or unnecessary, with practical contributions still depending on amounts and nutritional need.
Partner coverage
The counted ingredients stand alone or have their recognized partner; no extra benefit from combining them is established.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
All counted ingredients clear the saved minimum amount criterion, which is not a proven bone-treatment dose.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Magnesium (TRAACS Magnesium Bisglycinate Chelate) | 400 mg |
Magnesium (TRAACS Magnesium Bisglycinate Chelate) · 400 mg OverallScore90
Each serving provides 400 mg of magnesium as bisglycinate. A branded magnesium material is recorded, and the whole-product serving costs about $0.59.
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
The label identifies magnesium bisglycinate as the magnesium source. A named branded magnesium material is recorded in the evaluation.
Magnesium Form & Absorption Potential
Magnesium bisglycinate receives a favorable form assessment; that assessment does not specify how much is absorbed.
Patented Materials & Chelation Quality
A named branded magnesium material is recorded in the evaluation.
Dose, Safety & Label Transparency90
The label states 400 mg of magnesium per serving, a substantial amount. No qualifying cofactor amount is recorded in the evaluated facts.
Elemental Yield Transparency
The label explicitly states 400 mg of elemental magnesium per serving.
Therapeutic Dosage Alignment
400 mg of magnesium per serving is a substantial amount in the evaluation.
Synergistic Formulation Logic
The facts record 0 mg of calcium and no qualifying cofactor amount.
Value70
A whole-product serving costs about $0.59; the evaluation gives its value a mixed assessment for this form.
Price Per Elemental Quality
The price is about $0.59 per whole-product serving, and the evaluation gives its value a mixed assessment for this form.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Association between Serum Magnesium and Fractures: A Systematic Review and Meta-Analysis of Observational Studies.
- Bioabsorbable Magnesium-Based Materials Potential and Safety in Bone Surgery: A Systematic Review.
- Vascularized bone grafting fixed by biodegradable magnesium screw for treating osteonecrosis of the femoral head.
- An update on magnesium and bone health.
- Sex-specific differences in the association of magnesium intake with femoral neck bone mineral density among older adults.
- Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies.
- Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies.
- Quantitative Association Between Serum/Dietary Magnesium and Cardiovascular Disease/Coronary Heart Disease Risk: A Dose-Response Meta-analysis of Prospective Cohort Studies.
- Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
- Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.
- Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial.
- Total magnesium intake and risk of frailty in older women.
- Red blood cell magnesium and chronic fatigue syndrome.
- Exercise, magnesium and immune function.
- Perioperative systemic magnesium to minimize postoperative pain: a meta-analysis of randomized controlled trials.
- Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2).
- Association of magnesium sulfate use with mortality in critically ill patients with sepsis: a retrospective propensity score-matched cohort study.
- Hypomagnesemia and Mortality in Incident Hemodialysis Patients.
- The effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial.
- Efficacy of oral magnesium therapy in the treatment of chronic constipation in spastic cerebral palsy children: a randomized controlled trial.